A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitro
Yujie Xing(Wannan Medical College), Xiang Kong(Wannan Medical College), Xin-ming Yao(First Affiliated Hospital of Wannan Medical College), Yi Cheng(Wannan Medical College), Yue Sun(Wannan Medical College), Biaohu Liu(Wannan Medical College), Kun Lv(Anhui Normal University), Shujun Wan(Wannan Medical College), Qiang Hua(First Affiliated Hospital of Wannan Medical College), Yan Zhang(IHI Corporation (United States)), Xiang-jian Meng(First Affiliated Hospital of Wannan Medical College), Min Zhong(Affiliated Hospital of Southwest Medical University), Jinhan Cheng(First Affiliated Hospital of Wannan Medical College)
Cited by 72
Related Papers
CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress–induced myocardial necroptosis
|Nature Medicine|2016|791
Formal Carbon Insertion of <i>N-</i>Tosylhydrazone into B–B and B–Si Bonds: <i>gem</i>-Diborylation and <i>gem</i>-Silylborylation of sp<sup>3</sup> Carbon
|Organic Letters|2013|176
Negative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53
|Molecular Cell|2021|176
4-Hydroxy-2-nonenal protects against cardiac ischemia–reperfusion injury via the Nrf2-dependent pathway
|Journal of Molecular and Cellular Cardiology|2010|151